Medibio announces positive clinical study results
Filed with ASX · · 3 pages · English
Earlier from TrivarX
- Quarterly ASX Update and Cashflows
- Scientific breakthrough on objective diagnosis of PTSD
- Independent researchers present first data validating MEB
- Signed second agreement for Wellness
- MEB Signs Strategic Joint Development Agreement with Mayo Cl
Later from TrivarX
- Medibio initiates confirmatory study
- Medibio enters agreement with Mayo Clinc
- Medibio enters into an Agreement with Otsuka Pharmaceutical
- Response to ASX Query
- MEB completes heavily oversubscribed institutional placement
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX